breast cancer

Four drug types have been found to reduce breast cancer incidence by 38% in women at an increased risk of the disease, according to a Cancer Research UK study published in The Lancet.

The National Institute for Health and Clinical Excellence (NICE) is updating its clinical guideline on familial breast cancer.

Women could one day be diagnosed and treated for breast cancer through a simple blood test, researchers have said.

More people are set to beat cancer as treatments improve and diagnosis is made earlier, according to Cancer Research UK.

Carriers of certain gene mutations are at greater risk of developing breast cancer if exposed to chest X-rays, research has shown.

A breast cancer drug has been pulled from NHS treatment because it was not proving cost-effective, the National Institute for Health and Clinical Excellence (NICE) has reported.

The National Institute for Health and Clinical Excellence, (NICE), has opened a consultation on draft guidance which does not recommend bevacizumab (Avastin, Roche), for metastatic breast cancer, when used in combination with the chemotherapy drug, capecitabine....

Two more cancer drugs have been provisionally banned for NHS after it was decided they were too expensive for the potential results.

The PIP breast implant furore could prompt the creation of an insurance scheme for cosmetic surgery patients to prevent similar remedial problems in the future.

The National Institute for Health and Clinical Excellence (Nice) has banned another breast cancer drug from routine NHS use.